DNA binding properties of the nucleocapsid protein from human T-cell leukemia virus type-I

International Journal of Oncology

Volumn 13, Issue 4, 1998, Pages 749-755

  Chechelnitsky, Galina ^a   Priel, Esther ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

HTLV I; Nucleocapsid protein; Topoisomerase; Unwinding activity

Indexed keywords

CAPSID PROTEIN; DNA FRAGMENT; DNA TOPOISOMERASE; RNA DIRECTED DNA POLYMERASE; VIRUS PROTEIN;

ARTICLE; DNA BINDING; DNA DENATURATION; DNA PROTEIN COMPLEX; ENZYME ACTIVITY; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS NUCLEOCAPSID;

EID: 0031666451     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.4.749     Document Type: Article

References (45)

1. Dickson C, Eisenman R, Fan H, Hunter E and Reich N: Protein biosynthesis and assembly. In: RNA Tumor Viruses. Weiss R, Teich N, Varmus H and Coffin J (eds.) 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp513-648, 1985.
2. Darlix JC, Lapadat-Tapolsky M, De Rocquigny H and Rouques BP: First glimpses at strucure-function relationships of nucleocapsid protein of retroviruses. J Mol Biol 254: 523-537, 1995.
3. Covey SN: Amino acid sequence homology in GAG region of reverse transcribing elements and the coat protein gene of cawliflower mosaic virus. Nucleic Acids Res 14: 623-633, 1986.
4. Henderson LE, Bowers MA, Sowder RC II, Serabyn SA, Johnson DG, Bess JW Jr, Arthur LO, Bryant DK and Fenselan C: Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modificatons, proteolytic processings, and complete amino acid sequences. J Virol 66: 1856-1865, 1992.
5. Bess JW, Powell PJ, Issaq HJ, Schumack LJ, Grimes MK, Henderson LE and Arthur LO: Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type 1, and other retroviruses. J Virol 66: 840-847, 1992.
6. Aldovini A and Young RA: Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J Virol 64: 1920-1926, 1990.
7. Gorelick RJ, Henderson LE, Hamser JP and Rein A: Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a 'zinc finger-like' protein sequence. Proc Natl Acad Sci USA 85: 8420-8424, 1988.
8. Gorelick RJ, Nigida SM Jr, Bess JW Jr, Arthur LO, Henderson LE and Rein A: Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J Virol 64: 3207-3211, 1990.
9. Meric C and Spahr RF: Rous sarcoma virus nucleic acid-binding protein pi2 is necessary for viral 70S RNA dimer formation and packaging. J Virol 60: 450-459, 1986.
10. Meric C, Gouilloud E and Spahr RF: Mutations in Rous sarcoma virus nuclebcapsid protein p12 (NC): deletions of Cys-His boxes. J Virol 62: 3328-3333, 1988.
11. Meric C and Goff SP: Characterization of Moloney murine leukemia virus mutants with single amino acid substitution in the Cys-His box of the nucleocapsid protein. J Virol 63: 1558-1568, 1988.
12. Richardson J, Child L and Lever A: Packaging of HIV-1 RNA requires cis acting sequences outside the 5' leader region. J Virol 67: 3997-4005, 1993.
13. Housset V, De Rocquigny H, Roques B and Darlix JL: Basic amino acids flanking the zinc finger of Moloney murine leukemia virus nucleocapsid protein NCp10 are critical for virus infectivity. J Virol 67: 2537-2545, 1993.
14. Pratts AC, Sarih L, Gabus C, Litvak S, Keith G and Darlix JL: Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J 7: 1777-1783, 1988.
15. De Rocquigny H, Gabus C, Vincent A, Fournie-Zaluski MC, Roque B and Darlix JL: Viral RNA annealing activities of HIV-1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc Natl Acad Sci USA 89: 6472-6476, 1992.
16. Karpel RL, Henderson LE and Oroszlan S: Interactions of retroviral structural proteins with single-stranded nucleic acids. J Biol Chem 262: 4961-4967, 1987.
17. Nissen-Meyer J and Abraham A: Specificity of RNA binding by the structural protein (plO) of F-MuLV. J Mol Biol 142: 19-28, 1980.
18. Tsukahara T, Komatsu H, Kubo M, Obata F and Tozawa H: Binding properties of human immunodeficiency virus type 2 (HIV-2) RNA corresponding to the packaging signal to its nucleocapsid protein. Biochem Mol Biol Int 40: 33-42, 1996.
19. Khan R and Giedroc DP: Nucleic acid binding properties of recombinant Zn2 HIV-1 nucleocapsid protein are modulated by COOH-terminal processing. J Biol Chem 269: 22538-22546, 1994.
20. Dannull J, Surovoy A, Jung G and Moelling K: Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino residues. EMBO J 13: 1525-1533, 1994.
21. Summers MF, Henderson LE, Chance MR, Bess JW, South TL, Blake PR, Sagi I, Perez-Alvarado G, Sowder RC III, Hare DR and Arthur LO: Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci 1: 563-574, 1992.
22. Tsuchihashi Z and Brown PO: DNA strand exchange and selective DNA annealing promoted by the human immuno-deficiency virus type 1 nucleocapsid protein. J Virol 68: 5863-5870, 1994.
23. Lapadat-Tapolsky M, De Rocquigny H, van Gent D, Roques B, Plaasterk R and Darlix JL: Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in viral life cycle. Nucleic Acids Res 21: 831-839, 1993.
24. Lapadat-Tapolsky M, Pernelle C, Borie C and Darlix JL: Analysis of the nucleic acid annealing activities of nucleo-capsid protein from HIV-1. Nucleic Acids Res 23: 2434-2441, 1995.
25. Zhang Z, Kang SM, Le Blanc A, Hajduk SL and Morrow CD: Nucleotide sequences within the US region of the viral RNA genome are the major determinants for a human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA (His). Virology 226: 306-317, 1996.
26. Allen P, Collins B, Brown D, Hostomsky Z and Gold L: A specific RNA structural motif mediates high affinity binding by the HIV-1 nucleocapsid protein (NCp7). Virology 225: 306-315, 1996.
27. Berglund JA, Charpentier B and Rosbash M: A high affinity binding site for the HIV-1 nucleocapsid protein. Nucleic Acids Res 25: 1042-1049, 1997.
28. Priel E, Aflalo E, Seri I, Henderson LE, Arthur LO, Aboud M, Segal S and Blair DG: DNA binding properties of the zinc-bound and zinc-free HIV nucleocapsid protein: supercoiled DNA unwinding and DNA-protein cleavable complex formation. FEBS Lett 362: 59-64, 1995.
29. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD and Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415-7419, 1980.
30. Poiesz BJ, Ruscetti FW, Reitz MS, Kalyanaramane VS and Gallo RC: Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukemia. Nature 294: 268-271, 1981.
31. Franchini G: Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 86: 3619-3639, 1995.
32. Sambrook J, Fritsch EF and Maniatis T (eds): DNA gel electrophoresis. In: Molecular Cloning a Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp6.45-6.46, 1989.
33. Chow CK, Johnson TL and Pearson GD: A novel method for the detection and quantitation of eukaryotic topoisomerase I. Biotechniques 3: 290-297, 1985.
34. Shuman S and Moss B: Identification of a vaccinia virus gene encoding a type I DNA topoisomerase. Proc Natl Acad Sci USA 84: 7478-7482, 1987.
35. Towbin H, Staehelin T and Gordon J: Electrophoretic transfer to proteins from polyacrylamid gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
36. Wang JC: DNA topoisomerases. Annu Rev Biochem 65: 635-692, 1996.
37. Pommier Y: DNA topoisomerases I and II in cancer chemotherapy: update and perspectives. Cancer Chemother Pharmacol 32: 103-108, 1993.
38. Drummond JE, Mounts P, Gorelick RJ, Casas-Finet JR, Bosche WJ, Henderson LE, Waters DJ and Arthur LO: Wild-type and mutant HIV-1 nucleocapsid proteins increase the proportion of long cDNA transcripts by viral reverse transcriptase. AIDS Res Hum Retroviruses 13: 533-543, 1997.
39. Lapadat-Tapolsky M, Gabus C, Rau M and Darlix JL: Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in variability. J Mol Biol 268: 250-260, 1997.
40. Berthoux L, Pechoux C, Ottmann M, Morel G and Darlix JC: Mutations in the N terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis. J Virol 71: 6973-6981, 1997.
41. Zhang Y and Barklis E: Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation. J Virol 69: 5716-5722, 1995.
42. Rice WG, Baker DC, Schaeffer CA, Graham L, Bu M, Terpening S, Clanton D, Schultz R, Bader JP, Buckheit RW, Field L, Singh PK and Turpin JA: Inhibition of multiple phases of human immunodeficiency virus type 1 replication by adithian compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins. Antimicrob Agents Chemother 41: 419-426, 1997.
43. Domagala JM, Bader JP, Gogliotti RD, Sanchez JP, Scholten J, Harvey P, Holler T, Gracheck S, Hupe D, Rice WG and Schultz R: A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: the 2,2′-dithiobisbenamides. Bioorg Med Chem 5: 569-579, 1997.
44. Matsrafi L, Aflalo E, Blair DG and Priel E: Isolation of an 11 kDa protein associated with the topoisomerase I activity from equine infectious anemia virus. Biochem Biophys Res Commun 220: 1028-1035, 1996.
45. Carteau S, Batson SC, Pojjak L, Mouscadet JF, De Rocquigny H, Darlix JL, Roques BP, Kas E and Auclair C: Human immunodeficiency virus type 1 nucleocapsid protein specifically stimulates Mg dependent DNA integration in vitro. J Virol 71: 6225-6229, 1997.